Baebies Receives FDA Breakthrough Device Designation for First Point-of-Care Heparin Monitoring Test
A Digital Microfluidic Sepsis Diagnostic Predicts Bacterial Infection Status Using Host Transcription Response
Novel Fluorometric Assay for Pediatric Anti-Factor Xa Testing: Minimizing Bilirubin and Hemolysis Interference in Whole Blood
Investigation into the Prevalence of G6PD Deficiency in a Pediatric African American Population Using A Near-Patient Diagnostic Platform
Digital Microfluidic Point of Care Platform for Molecular Detection of STI Pathogens Including Drug-Resistant Gonorrhea
A Digital Microfluidic Sepsis Diagnostic Predicts Bacterial Infection Status Using Host Transcriptomic Response
Preliminary Clinical Method Comparison of a Point-of-Care Platform for anti-Factor Xa in Pediatric Patients on Heparin Therapy
Baebies Awarded $2.7 Million NIH Grant for Rapid, Near-patient Heparin Monitoring Requiring Low Sample Volume
Baebies Awarded up to $11.6 Million from CARB-X for the Development of a Diagnostic Platform with Rapid Results for Sepsis
